Kjeldsen L, Bjerrum O W, Hovgaard D, Johnsen A H, Sehested M, Borregaard N
Department of Hematology L, University Hospital, Copenhagen, Denmark.
Eur J Haematol. 1992 Oct;49(4):180-91. doi: 10.1111/j.1600-0609.1992.tb00045.x.
Human neutrophil gelatinase was purified to apparent homogeneity. The N-terminal amino-acid sequence of the purified enzyme could be aligned to an internal part of the cDNA-derived amino-acid sequence of 92-kDa type IV collagenase from SV 40-transfected human lung fibroblasts and from a TPA differentiated monocytic cell line, U937. Total amino-acid composition of U937 and neutrophil gelatinases was identical. Gelatinase was susceptible to treatment with o- and n-glycanase, indicating that posttranslational addition of oligosaccharide side chains occurs. An enzyme-linked immunosorbent assay for gelatinase was developed using specific polyclonal rabbit antibodies. The assay was specific, sensitive, accurate, and reproducible. Ninety percent range for plasma gelatinase from normal subjects was 17.3 to 102.9 ng/ml. In patients treated with cytostatic agents for non-Hodgkin's lymphoma, there was a parallel drop in plasma gelatinase and peripheral granulocyte count. This indicates that plasma gelatinase is a marker for circulating neutrophils. Plasma gelatinase does not seem to reflect bone marrow cellularity.
人中性粒细胞明胶酶被纯化至表观均一性。纯化酶的N端氨基酸序列可与来自SV40转染的人肺成纤维细胞和TPA分化的单核细胞系U937的92-kDa IV型胶原酶的cDNA衍生氨基酸序列的内部部分比对。U937和中性粒细胞明胶酶的总氨基酸组成相同。明胶酶对o-和n-聚糖酶处理敏感,表明存在翻译后寡糖侧链的添加。使用特异性兔多克隆抗体制备了明胶酶的酶联免疫吸附测定法。该测定法具有特异性、灵敏性、准确性和可重复性。正常受试者血浆明胶酶的90%范围为17.3至102.9 ng/ml。在接受细胞抑制剂治疗非霍奇金淋巴瘤的患者中,血浆明胶酶和外周粒细胞计数平行下降。这表明血浆明胶酶是循环中性粒细胞的标志物。血浆明胶酶似乎不能反映骨髓细胞数量。